1,380
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine

Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs

, , , , , , , , , , , , , & show all
Pages 2199-2210 | Received 17 Jan 2014, Accepted 04 May 2014, Published online: 08 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

AJ Graves & DA Hokey. (2015) Tuberculosis vaccine development: Shifting focus amid increasing development challenges. Human Vaccines & Immunotherapeutics 11:8, pages 1910-1916.
Read now

Articles from other publishers (21)

Sherry L. Kurtz, Lara R. Mittereder, Chelsea C. Lehman, Hamda Khan, Victoria A. Gould & Karen L. Elkins. (2023) Intravenous BCG Vaccination of Diversity Outbred Mice Results in Moderately Enhanced Protection against Challenge with Mycobacterium tuberculosis Compared to Intradermal Vaccination. Infection and Immunity 91:7.
Crossref
Zhidong Hu, Shui-Hua Lu, Douglas B. Lowrie & Xiao-Yong Fan. (2022) Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development. Frontiers in Immunology 13.
Crossref
Surendra Saraf, Shailesh Jain, Rudra Narayan Sahoo & Subrata Mallick. (2020) Lipopolysaccharide derived alginate coated Hepatitis B antigen loaded chitosan nanoparticles for oral mucosal immunization. International Journal of Biological Macromolecules 154, pages 466-476.
Crossref
Michel P. M. Vierboom, Agnes L. Chenine, Patricia A. Darrah, Richard A. W. Vervenne, Charelle Boot, Sam O. Hofman, Claudia C. Sombroek, Karin Dijkman, Mohamed A. Khayum, Marieke A. Stammes, Krista G. Haanstra, Chantal Hoffmann, Doris Schmitt, Nathalie Silvestre, Alexander G. White, H. Jacob Borish, Robert A. Seder, Nadia Ouaked, Stephane Leung-Theung-Long, Geneviève Inchauspé, Ravi Anantha, Mary Limbach, Thomas G. Evans, Danilo Casimiro, Maria Lempicki, Dominick J. Laddy, Aurelio Bonavia & Frank A. W. Verreck. (2020) Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques. npj Vaccines 5:1.
Crossref
Patricia Méndez‐Samperio. (2019) Novel vaccination strategies and approaches against human tuberculosis. Scandinavian Journal of Immunology 90:2.
Crossref
Lewis K. Schrager, Rebecca C. Harris & Johan Vekemans. (2019) Research and development of new tuberculosis vaccines: a review. F1000Research 7, pages 1732.
Crossref
Lewis K. Schrager, Rebecca C. Harris & Johan Vekemans. (2018) Research and development of new tuberculosis vaccines: a review. F1000Research 7, pages 1732.
Crossref
J Wolf. 2018. Comprehensive Toxicology. Comprehensive Toxicology 852 872 .
Rubina Bunjun, Catherine Riou, Andreia P Soares, Narjis Thawer, Tracey L Müller, Agano Kiravu, Zekarias Ginbot, Tolu Oni, Rene Goliath, Barbara Kalsdorf, Florian von Groote-Bidlingmaier, Willem Hanekom, Gerhard Walzl, Robert J Wilkinson & Wendy A Burgers. (2017) Effect of HIV on the Frequency and Number of Mycobacterium tuberculosis–Specific CD4+ T Cells in Blood and Airways During Latent M. tuberculosis Infection. The Journal of Infectious Diseases 216:12, pages 1550-1560.
Crossref
Taylor W Foreman, Smriti Mehra, Andrew A Lackner & Deepak Kaushal. (2017) Translational Research in the Nonhuman Primate Model of Tuberculosis. ILAR Journal 58:2, pages 151-159.
Crossref
Deborah A. Lewinsohn, David M. Lewinsohn & Thomas J. Scriba. (2017) Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination. Frontiers in Immunology 8.
Crossref
Frank A.W. Verreck, Elma Z. Tchilian, Richard A.W. Vervenne, Claudia C. Sombroek, Ivanela Kondova, Okke A. Eissen, Vinod Sommandas, Nicole M. van der Werff, Ernst Verschoor, Gerco Braskamp, Jaco Bakker, Jan A.M. Langermans, Peter J. Heidt, Tom H.M. Ottenhoff, Klaas W. van Kralingen, Alan W. Thomas, Peter C.L. Beverley & Clemens H.M. Kocken. (2017) Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails. Tuberculosis 104, pages 46-57.
Crossref
Diane L. Bolton, Kaimei Song, Georgia D. Tomaras, Srinivas Rao & Mario Roederer. (2017) Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques. Vaccine 35:4, pages 639-646.
Crossref
Nnamdi Nwachukwu. (2016) Comparative Effectiveness of Vaccines for Tuberculosis in Endemic Countries: A Systematic Review and Meta-analysis. International Journal of Vaccines & Vaccination 3:1.
Crossref
Ellen F. Young, Anthony J. Hickey & Miriam Braunstein. 2016. Drug Delivery Systems for Tuberculosis Prevention and Treatment. Drug Delivery Systems for Tuberculosis Prevention and Treatment 111 130 .
Sam Afkhami, Yushi Yao & Zhou Xing. (2016) Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens. Molecular Therapy - Methods & Clinical Development 3, pages 16030.
Crossref
A. D. White, C. Sarfas, K. West, L. S. Sibley, A. S. Wareham, S. Clark, M. J. Dennis, A. Williams, P. D. Marsh & S. A. Sharpe. (2015) Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques. Clinical and Vaccine Immunology 22:9, pages 992-1003.
Crossref
. (2015) Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings. Vaccine 33:26, pages 3038-3046.
Crossref
Nicola Principi & Susanna Esposito. (2015) The present and future of tuberculosis vaccinations. Tuberculosis 95:1, pages 6-13.
Crossref
Benjamin M.N. Kagina, Michele D. Tameris, Hennie Geldenhuys, Mark Hatherill, Brian Abel, Gregory D. Hussey, Thomas J. Scriba, Hassan Mahomed, Jerald C. Sadoff, Willem A. Hanekom, Nazma Mansoor, Jane Hughes, Marwou de Kock, Wendy Whatney, Hadn Africa, Colleen Krohn, Ashley Veldsman, Angelique Luabeya Kany Kany, Macaya Douoguih, Maria Grazia Pau, Jenny Hendriks, Bruce McClain, Jacqueline Benko, Margaret A. Snowden & David A. Hokey. (2014) The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine 32:45, pages 5908-5917.
Crossref
Patricia A. Darrah, Diane L. Bolton, Andrew A. Lackner, Deepak Kaushal, Pyone Pyone Aye, Smriti Mehra, James L. Blanchard, Peter J. Didier, Chad J. Roy, Srinivas S. Rao, David A. Hokey, Charles A. Scanga, Donata R. Sizemore, Jerald C. Sadoff, Mario Roederer & Robert A. Seder. (2014) Aerosol Vaccination with AERAS-402 Elicits Robust Cellular Immune Responses in the Lungs of Rhesus Macaques but Fails To Protect against High-Dose Mycobacterium tuberculosis Challenge . The Journal of Immunology 193:4, pages 1799-1811.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.